QWP
NVO

Quotient Wealth Partners’s Novo Nordisk NVO Stock Holding History

Quotient Wealth Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Buy
8,989
+993
+12% +$42.7K 0.01% 238
2026
Q1 		$294K Sell
7,996
-1,095
-12% -$51.9K 0.01% 292
2025
Q4 		$463K Buy
9,091
+177
+2% +$9.05K 0.01% 206
2025
Q3 		$495K Sell
8,914
-666
-7% -$39K 0.01% 195
2025
Q2 		$661K Buy
9,580
+165
+2% +$11.2K 0.02% 154
2025
Q1 		$654K Buy
9,415
+430
+5% +$35.5K 0.02% 150
2024
Q4 		$773K Sell
8,985
-599
-6% -$64.8K 0.03% 127
2024
Q3 		$1.14M Sell
9,584
-1,812
-16% -$242K 0.04% 99
2024
Q2 		$1.63M Sell
11,396
-16,421
-59% -$2.18M 0.06% 73
2024
Q1 		$3.57M Sell
27,817
-23,720
-46% -$2.82M 0.13% 50
2023
Q4 		$5.33M Buy
+51,537
New +$5.1M 0.21% 47

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Quotient Wealth Partners's NVO Position: Q2 2026 in Review

Quotient Wealth Partners increased its Novo Nordisk (NVO) stake by 12% in Q2 2026, buying an estimated $42.7K and bringing the position to 8,989 shares worth $431K. The position accounts for 0.01% of the portfolio, ranked #238.

Quotient Wealth Partners first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.33M in Q4 2023. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Quotient Wealth Partners held 8,989 shares of Novo Nordisk worth $431K as of Q2 2026.
  • Quotient Wealth Partners bought 993 Novo Nordisk shares in Q2 2026, an estimated $42.7K.
  • Novo Nordisk made up 0.01% of Quotient Wealth Partners's portfolio in Q2 2026, its #238 holding.
  • Quotient Wealth Partners first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Quotient Wealth Partners's Novo Nordisk position peaked at $5.33M in Q4 2023.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.